Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295 in healthy adults
Early randomized studies in healthy adults measured changes in circulating growth hormone and IGF-I after the long-acting GHRH analogue CJC-1295.
Study limitations
Hormone concentrations are surrogate endpoints. These short studies do not establish benefits for recovery, body composition, or long-term safety. Long-acting CJC-1295 must not be conflated with other products sold under similar names.
